Login to Your Account



Financings Roundup


Friday, February 3, 2012

• Tranzyme Pharma Inc., of Research Triangle Park, N.C., said it received an additional $9.3 million in term loan proceeds through an amendment and restatement of its existing debt financing facility with Oxford Finance LLC and Horizon Technology Finance Corp. The firm will use a portion of the new proceeds to pay off part of its existing debt, and the financing is expected to extend its cash runway into the fourth quarter of 2013.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription